340 related articles for article (PubMed ID: 23768767)
21. Body mass index, diabetes, and triple-negative breast cancer prognosis.
Tait S; Pacheco JM; Gao F; Bumb C; Ellis MJ; Ma CX
Breast Cancer Res Treat; 2014 Jul; 146(1):189-97. PubMed ID: 24869799
[TBL] [Abstract][Full Text] [Related]
22. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
23. Is conservative surgery a good option for patients with "triple negative" breast cancer?
Martinez-Ramos D; Escrig-Sos J; Torrella-Ramos A; Alcalde-Sanchez M; Salvador-Sanchis JL
Breast; 2012 Jun; 21(3):401-5. PubMed ID: 22579462
[TBL] [Abstract][Full Text] [Related]
24. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
25. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
[TBL] [Abstract][Full Text] [Related]
26. The Role of Body Mass Index in Triple Negative Breast Cancer.
Cakar B; Muslu U; Erdogan AP; Ozisik M; Ozisik H; Tunakan Dalgic C; Durusoy R; Karaca B; Sezgin C; Karabulut B; Uslu R
Oncol Res Treat; 2015; 38(10):518-22. PubMed ID: 26452262
[TBL] [Abstract][Full Text] [Related]
27. Is obesity an independent prognosis factor in woman breast cancer?
Majed B; Moreau T; Senouci K; Salmon RJ; Fourquet A; Asselain B
Breast Cancer Res Treat; 2008 Sep; 111(2):329-42. PubMed ID: 17939036
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of osteopontin in patients with triple-negative breast cancer.
Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J
Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545
[TBL] [Abstract][Full Text] [Related]
29. Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection.
Choi Y; Park SK; Ahn KJ; Cho H; Kim TH; Yoon HK; Lee YH
J Korean Med Sci; 2016 Jun; 31(6):886-91. PubMed ID: 27247497
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of delays in time to treatment in triple negative breast cancer.
Eastman A; Tammaro Y; Moldrem A; Andrews V; Huth J; Euhus D; Leitch M; Rao R
Ann Surg Oncol; 2013 Jun; 20(6):1880-5. PubMed ID: 23292484
[TBL] [Abstract][Full Text] [Related]
31. Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation.
Brewer RJ; Lanfear DE; Sai-Sudhakar CB; Sundareswaran KS; Ravi Y; Farrar DJ; Slaughter MS
J Heart Lung Transplant; 2012 Feb; 31(2):167-72. PubMed ID: 22305378
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and survival analysis of T1mic, a, bN0M0 breast cancer.
Li J; Liu X; Tong Z
Jpn J Clin Oncol; 2012 Jun; 42(6):471-6. PubMed ID: 22493058
[TBL] [Abstract][Full Text] [Related]
33. Extremes in body mass index affect overall survival in women with cervical cancer.
Clark LH; Jackson AL; Soo AE; Orrey DC; Gehrig PA; Kim KH
Gynecol Oncol; 2016 Jun; 141(3):497-500. PubMed ID: 27058838
[TBL] [Abstract][Full Text] [Related]
34. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
Ono M; Tsuda H; Shimizu C; Yamamoto S; Shibata T; Yamamoto H; Hirata T; Yonemori K; Ando M; Tamura K; Katsumata N; Kinoshita T; Takiguchi Y; Tanzawa H; Fujiwara Y
Breast Cancer Res Treat; 2012 Apr; 132(3):793-805. PubMed ID: 21562709
[TBL] [Abstract][Full Text] [Related]
35. A gene transcription signature of obesity in breast cancer.
Creighton CJ; Sada YH; Zhang Y; Tsimelzon A; Wong H; Dave B; Landis MD; Bear HD; Rodriguez A; Chang JC
Breast Cancer Res Treat; 2012 Apr; 132(3):993-1000. PubMed ID: 21750966
[TBL] [Abstract][Full Text] [Related]
36. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial.
Doehner W; Schenkel J; Anker SD; Springer J; Audebert HJ
Eur Heart J; 2013 Jan; 34(4):268-77. PubMed ID: 23076781
[TBL] [Abstract][Full Text] [Related]
37. The impact of obesity on breast cancer: a retrospective review.
Haakinson DJ; Leeds SG; Dueck AC; Gray RJ; Wasif N; Stucky CC; Northfelt DW; Apsey HA; Pockaj B
Ann Surg Oncol; 2012 Sep; 19(9):3012-8. PubMed ID: 22451232
[TBL] [Abstract][Full Text] [Related]
38. Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking.
Fotopoulou C; Richter R; Braicu EI; Kuhberg M; Feldheiser A; Schefold JC; Lichtenegger W; Sehouli J
Ann Surg Oncol; 2011 Sep; 18(9):2629-37. PubMed ID: 21394662
[TBL] [Abstract][Full Text] [Related]
39. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
[TBL] [Abstract][Full Text] [Related]
40. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer.
Bergom C; Kelly T; Bedi M; Saeed H; Prior P; Rein LE; Szabo A; Wilson JF; Currey AD; White J
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):65-71. PubMed ID: 27511848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
